Abstract

The purpose of this article was to demonstrate the approach of the Supreme Administrative Court to ruling in cases of the “reverse distribution chain” and its effects for the entities operating public pharmacies that participate in the “reverse distribution chain”. The judgments of the Supreme Administrative Court in this area were analysed, taking into account the new legal standard prohibiting wholesale trade in medicinal products by a public pharmacy, regulations existing before the above legal standard was implemented, and the effects associated with the participation in the “reverse distribution chain”. The most important conclusion of the above analysis was the fact that the Pharmaceutical Law, when regulating trade in medicinal products, defines the principles of such trade and only on the basis thereof may the activity be conducted.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call